H. M. Calvet and T. T. Yoshikawa, INFECTIONS IN DIABETES, Infectious Disease Clinics of North America, vol.15, issue.2, pp.407-421, 2001.
DOI : 10.1016/S0891-5520(05)70153-7

F. Carrat and A. Flahault, Influenza vaccine: The challenge of antigenic drift, Vaccine, vol.25, issue.39-40, pp.6852-6862, 2007.
DOI : 10.1016/j.vaccine.2007.07.027

R. J. Diepersloot, K. P. Bouter, W. E. Beyer, J. B. Hoekstra, and N. Masurel, Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus, Diabetologia, vol.12, issue.6, pp.397-401, 1987.
DOI : 10.1007/BF00292541

J. J. Donnelly, J. B. Ulmer, J. W. Shiver, and M. A. Liu, DNA VACCINES, DNA vaccines, pp.617-648, 1997.
DOI : 10.1146/annurev.immunol.15.1.617

R. J. Drape, M. D. Macklin, L. J. Barr, S. Jones, J. R. Haynes et al., Epidermal DNA vaccine for influenza is immunogenic in humans, Vaccine, vol.24, issue.21, pp.4475-4481, 2006.
DOI : 10.1016/j.vaccine.2005.08.012

D. W. Drell and A. L. Notkins, Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus, Diabetologia, vol.1, issue.Suppl 1, pp.132-143, 1987.
DOI : 10.1007/BF00274217

S. L. Epstein, W. Kong, J. A. Misplon, C. Y. Loa, T. M. Tumpey et al., Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein, Vaccine, vol.23, issue.46-47, pp.5404-5410, 2005.
DOI : 10.1016/j.vaccine.2005.04.047

S. L. Epstein, A. Stack, J. A. Misplon, C. Y. Lo, H. Mostowski et al., Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge, International Immunology, vol.12, issue.1, pp.91-101, 2000.
DOI : 10.1093/intimm/12.1.91

S. E. Geerlings and A. Hoepelman, Immune dysfunction in patients with diabetes mellitus (DM), FEMS Immunology & Medical Microbiology, vol.26, issue.3-4, pp.259-265, 1999.
DOI : 10.1111/j.1574-695X.1999.tb01397.x

M. Giese, DNA-antiviral vaccines: new development and approaches?-a review, Virus Genes, vol.17, pp.211-232, 1998.

A. Jamali, M. H. Roostaee, H. Soleimanjahi, F. G. Pakdel, and T. Bamdad, DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge, Comparative Immunology, Microbiology and Infectious Diseases, vol.30, issue.2, pp.71-80, 2007.
DOI : 10.1016/j.cimid.2006.10.002

C. M. James, M. Y. Abdada, J. P. Mansfield, H. K. Jacobsen, A. Rezazadeh et al., Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein, Vaccine, vol.25, issue.10, pp.1856-1867, 2007.
DOI : 10.1016/j.vaccine.2006.10.038

J. Kaiser, A One-Size-Fits-All Flu Vaccine?, Science, vol.312, issue.5772, pp.380-382, 2006.
DOI : 10.1126/science.312.5772.380

S. Katz, B. Klein, I. Elian, P. Fishman, and M. Djaldetti, Phagocytotic Activity of Monocytes from Diabetic Patients, Diabetes Care, vol.6, issue.5, pp.479-482, 1983.
DOI : 10.2337/diacare.6.5.479

W. A. Kaye, M. N. Adri, J. S. Soeldner, S. L. Rabinowe, A. Kaldany et al., Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes Mellitus, New England Journal of Medicine, vol.315, issue.15, pp.920-924, 1986.
DOI : 10.1056/NEJM198610093151502

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

P. H. Nass, K. L. Elkins, and J. P. Weir, Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection, Vaccine, vol.19, issue.11-12, pp.1538-1546, 2001.
DOI : 10.1016/S0264-410X(00)00380-7

J. S. Nguyen-van-tam and A. W. Hampson, The epidemiology and clinical impact of pandemic influenza, Vaccine, vol.21, issue.16, pp.1762-1768, 2003.
DOI : 10.1016/S0264-410X(03)00069-0

K. Ohba, S. Yoshid, Z. Dewan, H. Shimura, N. Sakamaki et al., Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity, Vaccine, vol.25, issue.21, pp.4291-4300, 2007.
DOI : 10.1016/j.vaccine.2007.02.074

T. Orban, J. Kis, L. Szereday, P. Engelmann, K. Farkas et al., Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus, Journal of Autoimmunity, vol.28, issue.4, pp.177-187, 2007.
DOI : 10.1016/j.jaut.2007.01.002

P. C. Reading, J. Allison, E. C. Crouch, and E. M. Anders, Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?, J. Virol, vol.72, pp.6884-6887, 1998.

. Wilson, Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein, Vaccine, vol.25, pp.6845-6851, 2007.

S. Saha, S. Yoshida, K. Ohba, K. Matsui, T. Matsuda et al., A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus, Virology, vol.354, issue.1, pp.48-57, 2006.
DOI : 10.1016/j.virol.2006.04.015

M. Spatz, N. Eibl, S. Hink, H. M. Wolf, G. F. Fischer et al., Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells, Cellular Immunology, vol.221, issue.1, pp.15-26, 2003.
DOI : 10.1016/S0008-8749(03)00043-1

K. Subbarao and J. Katz, Avian influenza viruses infecting humans, Cellular and Molecular Life Sciences, vol.57, issue.12, pp.1770-1784, 2000.
DOI : 10.1007/PL00000657

. Dwarki, Heterologous protection against influenza by injection of DNA encoding a viral protein, Science, vol.259, pp.1745-1749, 1993.

J. B. Ulmer, R. R. Deck, C. M. Dewitt, A. Friedman, J. J. Donnelly et al., Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines, Vaccine, vol.12, issue.16, pp.1541-1544, 1994.
DOI : 10.1016/0264-410X(94)90081-7

R. Valdez, K. M. Narayan, L. S. Geiss, and M. M. Engelgau, Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults., American Journal of Public Health, vol.89, issue.11, pp.1715-1721, 1999.
DOI : 10.2105/AJPH.89.11.1715

S. Yamashiro, K. Kawakami, K. Uezu, T. Kinjo, K. Miyagi et al., Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis, Clinical and Experimental Immunology, vol.67, issue.1, pp.57-64, 2005.
DOI : 10.1016/0923-2494(96)83034-3

Q. Zhu, H. Chang, Y. Chen, F. Fang, C. Xue et al., Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice, Biochemical and Biophysical Research Communications, vol.329, issue.1, pp.87-94, 2005.
DOI : 10.1016/j.bbrc.2005.01.109